🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
2.970
0.00 (0.00%)
Nov 19, 2026, 4:00 PM EST - Market closed

Sionna Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Selling, General & Admin
39.9828.7213.279.716.77
Research & Development
74.3260.2657.2940.6334.61
Operating Expenses
114.388.9870.5650.3341.37
Operating Income
-114.3-88.98-70.56-50.33-41.37
Interest & Investment Income
10.9913.38.172.771.13
Other Non Operating Income (Expenses)
-0.010.420.70.3-
Pretax Income
-109.52-75.27-61.69-47.26-40.24
Net Income
-109.52-75.27-61.69-47.26-40.24
Net Income to Common
-109.52-75.27-61.69-47.26-40.24
Net Income Growth
-----
Shares Outstanding (Basic)
4540433
Shares Outstanding (Diluted)
4540433
Shares Change
50.15%935.60%31.56%13.80%-
EPS (Basic)
-2.43-1.88-15.99-16.11-15.61
EPS (Diluted)
-2.43-1.88-15.99-16.11-15.61
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-79.61-66.67-52.81-44.82-37.94
Free Cash Flow Per Share
-1.77-1.67-13.69-15.28-14.72
EBITDA
-113.69-88.34-69.89-49.75-41.25
D&A For EBITDA
0.620.650.670.580.12
EBIT
-114.3-88.98-70.56-50.33-41.37
SEC Filings: 10-K · 10-Q